Charles Schoch
Vermogen: 360 145 $ op 31-05-2026
Vermogen: 360 145 $ op 31-05-2026
Charles Schoch is Chief Financial Officer, Secretary & Treasurer at Candel Therapeutics, Inc. since 2024.
Previously, Mr. Schoch was Controller at Corbus Pharmaceuticals, Inc. from 2020 to 2021.
Education includes undergraduate studies at Elon University and graduate studies including an MBA at Northeastern University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 24-04-2026 | 43.391 ( 0,06% ) | 360 145 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| CANDEL THERAPEUTICS, INC. | Financieel Directeur/CFO | 12-01-2024 |
| Bedrijven | Functie | Einde |
|---|---|---|
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Comptroller/Controller/Auditor | 01-11-2021 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Elon University
Elon University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northeastern University
Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Candel Therapeutics, Inc.
Candel Therapeutics, Inc. BiotechnologyHealth Technology Develops and distributes immunotherapies for the treatment of cancer | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau